Low fetuin-A levels are associated with cardiovascular death: Impact of variations in the
gene encoding fetuin. Background Vascular calcification is common among end-stage renal …

Background: Cardiovascular disease (CVD) is the leading cause of mortality in hemodialysis
(HD). An elevated incidence of cardiovascular calcifications (CVC) is observed in HD. Fetuin …

In past decades, extraosseous (including cardiovascular) calcification was predominantly
regarded as a passive process of limited pathophysiological significance. It was thought that …

Calcifying atherosclerosis is an active process, which is controlled by calcification inhibitors
and inducers. Fetuin-A, an acute phase glycoprotein, is one of the more powerful circulating …

Background—Elevated circulating levels of fetuin-A in blood have been associated with
increased risk of cardiovascular disease. The goal of our study was to prospectively …

Abstract Background. Fetuin-A (α2-Heremans Schmid glycoprotein) has recently been
identified as a circulating inhibitor of calcification and is regulated as a negative acute phase …

Background. Fetuin-A is a serum protein that inhibits ectopic vascular calcification and is
present in lower concentrations in end-stage renal disease than in healthy controls. Whether …

Background—Fetuin-A is a multifunctional hepatic secretory protein that inhibits the action of
insulin in experimental animals. We evaluated the association between human serum fetuin …

Background—Fetuin-A, a protein almost exclusively secreted by the liver, induces insulin
resistance and subclinical inflammation in rodents. Circulating fetuin-A levels are elevated in …

Vascular calcification predicts an increased risk for cardiovascular events/mortality in
atherosclerosis, diabetes, and ESRD. Serum concentrations of α 2-Heremens-Schmid …